Alliance formed to research anti-cancer stem cell therapies

Thursday 17 June 2010

OncoMed Pharmaceuticals Inc of California and Bayer Schering Pharma AG of Berlin have entered into a global alliance to develop therapies that attack cancer stem cells.

 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany